[Adverse effects of new oncologic therapies]

MeSH terms

• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal, Humanized
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / adverse effects*
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Benzenesulfonates / administration & dosage
• Benzenesulfonates / adverse effects
• Bevacizumab
• Cetuximab
• Colonic Neoplasms / drug therapy
• Diagnosis, Differential
• Dose-Response Relationship, Drug
• Drug Delivery Systems
• Drug Eruptions / diagnosis*
• ErbB Receptors / antagonists & inhibitors
• Erlotinib Hydrochloride
• Everolimus
• Facial Dermatoses / chemically induced
• Facial Dermatoses / diagnosis
• Humans
• Indoles / administration & dosage
• Indoles / adverse effects
• Liver Neoplasms / drug therapy
• Liver Neoplasms / secondary
• Male
• Middle Aged
• Neoplasms / drug therapy*
• Niacinamide / analogs & derivatives
• Phenylurea Compounds
• Pyridines / administration & dosage
• Pyridines / adverse effects
• Pyrroles / administration & dosage
• Pyrroles / adverse effects
• Quinazolines / administration & dosage
• Quinazolines / adverse effects
• Sirolimus / administration & dosage
• Sirolimus / adverse effects
• Sirolimus / analogs & derivatives
• Sorafenib
• Sunitinib
• Trastuzumab